Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cyclotek Pty Ltd logo — Improving patient outcomes with accessible targeted radiopha...

Cyclotek Pty Ltd

Improving patient outcomes with accessible targeted radiopharmaceuticals.

Founded 2001 Australia Australia 106 employees Private Equity Health Care, Logistics +3

General Information

Company Name Cyclotek Pty Ltd
Founded Year 2001
Location Australia Australia
Employees 106
Industries Health Care, Logistics, Manufacturing +2
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Cyclotek Pty Ltd. To contact Cyclotek Pty Ltd, visit cyclotek.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cyclotek Pty Ltd compare?

A PDF of Cyclotek Pty Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cyclotek Pty Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cyclotek Pty Ltd

Cyclotek Pty Ltd, established in 2001, is a leading radiopharmaceutical manufacturer based in Australia and New Zealand, dedicated to enhancing patient outcomes with accessible targeted radiopharmaceuticals. The company's mission revolves around offering novel PET-tracers that deliver patient-specific insights into their disease state, enabling earlier diagnosis, more accurate disease assessment, and improved treatment planning and monitoring. Their product range spans across oncology and neurology, emphasizing patient-centered diagnostics. With a focus on Health Care, Logistics, Manufacturing, Pharmaceutical, and Supply Chain industries, Cyclotek is driven by the recent advancements in human genomics and chemistry innovation, aiming to advance therapeutic discovery, refine diagnostic pathways, and elevate personalized medicine standards. Notably, the company received a Private Equity Round investment on 06 November 2023 from Five V Capital, a significant development underscoring investor confidence in Cyclotek's endeavors. Cyclotek's commitment to pioneering advancements in the field of radiopharmaceuticals to enhance patient care aligns with emerging trends emphasizing the importance of personalized medicine. With its innovative approach and strategic focus, Cyclotek is poised to make a substantial impact in the healthcare industry, leveraging its expertise to drive positive change in patient outcomes.

Business keywords: Radiopharmaceuticals, PET-tracers, Oncology, Neurology, Personalized medicine, Patient outcomes, Diagnostic imaging, Therapeutic discovery, Genomics, Healthcare innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Five V Capital
Five V Capital
06 Nov 2023

Cyclotek Pty Ltd Alternatives & Competitors

View All Alternatives
Cyclotek Pty Ltd vs
Monrol Nuclear Products Co.
Monrol Nuclear Products Co. Turkey

Connecting your experiences and emotions throughout your journey.

6 employees
Manufacturing, Pharmaceutical
Compare Cyclotek Pty Ltd vs Monrol Nuclear Products Co.
Cyclotek Pty Ltd vs
Positron Corporation
Positron Corporation United States

Positron Corporation is a medical technology company that co-develops, manufactures, and sells state...

Post-IPO Equity
28 employees
Biotechnology, Health Care
Compare Cyclotek Pty Ltd vs Positron Corporation
Cyclotek Pty Ltd vs
Nusano
Nusano United States

Helping fight cancer by bringing supply stability and innovation to medical radioisotopes

Series A
140 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Cyclotek Pty Ltd

Improving patient outcomes with accessible targeted radiopharmaceuticals.
Cyclotek Pty Ltd was founded in 2001.
Cyclotek Pty Ltd is headquartered in Australia.
Cyclotek Pty Ltd operates in Health Care, Logistics, Manufacturing, Pharmaceutical and Supply Chain. Its work centres on Radiopharmaceuticals, PET-tracers, Oncology and Neurology.
Cyclotek Pty Ltd has approximately 106 employees.
Cyclotek Pty Ltd has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to Cyclotek Pty Ltd include Monrol Nuclear Products Co., Positron Corporation, Nusano, ARTBIO, ViewRay, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyclotek Pty Ltd and Monrol Nuclear Products Co. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cyclotek Pty Ltd, https://bouncewatch.com/company/cyclotek-pty-ltd, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout